Dr. Mitchell Ford Peabody D.O.
Hematologist-Oncologist | Hematology & Oncology
12000 E 12 Mile Rd Warren MI, 48093About
Mitchell F. Peabody, DO, is a hematologist-oncologist who diagnoses and treats patients at Tallahassee Memorial Healthcare/TMH Physician Partners - Cancer & Hematology Specialist in Tallahassee, FL. As a hematologist-oncologist, he has dedicated training and unique experience in diagnosing and treating blood diseases and blood cancers such as iron-deficiency anemia, hemophilia, sickle-cell disease, leukemia, and lymphoma. Hematologist-oncologists are trained in both hematology, the study of blood, and oncology, the study of cancer. Dr. Peabody has an impressive professional journey that spans four years and his expertise covers all facets of hematology and oncology.
Education and Training
Michigan State University Medical Degree 2009
Board Certification
Internal Medicine
Medical Oncology
Hematology
Provider Details
Expert Publications
Data provided by the National Library of MedicineAreas of expertise and specialization
Fellowships
- Providence Hospital Hematology-Oncology 2015
Internships
- St. John Macomb Hospital2010
Fellowships
- Providence Hospital2015Hematology-Oncology
Dr. Mitchell Ford Peabody D.O.'s Practice location
TALLAHASSEE, FL 32308Get Direction
Dr. Mitchell Ford Peabody D.O.'s reviews
Write ReviewPatient Experience with Dr. Peabody
Media Releases
Dr. Peabody is a hematologist-oncologist serving Tallahassee and the surrounding communities. He is associated with Tallahassee Memorial Healthcare – a private, not-for-profit community healthcare system committed to transforming care, advancing health, and improving lives with an ultimate vision to elevate the standards of our healthcare practice, quality and innovation in our region.
Dr. Peabody received his Doctor of Oncology (DO) from Michigan State University in 2009. He completed an internship at St. John Macomb hospital in 2010, his residency at Providence Hospital in 2012, and his fellowship at the same hospital in 2015. It was during his time he became specialized in hematology cncology and internal medicine.
Dr. Peabody is board-certified in hematology and medical oncology by the American Board of Internal Medicine. The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.
Oncology is a healthcare profession dedicated to the diagnosis and treatment of cancer. As on oncologist, Dr. Peabody diagnoses cancer through methods such as biopsy, endoscopy, X-ray, blood tests, ultrasound, and different forms of nuclear medicine. He will treat cancer through surgery, chemotherapy, radiotherapy, hormone therapy, or antibody treatments. If it is determined that a cancer cannot successfully be treated, he will then focus on providing palliative care, the use of pain medication to make a dying person more comfortable.
With 10 years of experience in the field, Dr. Peabody has treated thousands of patients.
Recommended Articles
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Living as a Hodgkin Lymphoma Survivor: Creating a New Normal
No one can ever truly be prepared for what it is like to live with cancer. Even the strongest survivors face setbacks, and some of the fiercest warriors share their stories of how they find their "new normals."Kimberly's storyWhen she was only 25, just five days before her wedding, Kimberly felt a...
- Can Multiple Myeloma be Asymptomatic?
Early treatment for persons suffering from multiple myeloma that is asymptomatic may not be beneficial. The initial stages for multiple myeloma do not show symptoms, and this is known as being asymptomatic.The treatment for persons with asymptomatic multiple myeloma should be deferred up to when the...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- 9/11 Ground Zero Worker's Lymphoma Improves with Clinical Trial
When the terrorist attacks occurred in New York on September 11th, 2001, Bart Zagami, a 61-year-old New York State Supreme Court officer, was in his office just a few blocks away from the World Trade Center in lower Manhattan. Days after the 9/11 terrorist attacks, Zagami spent his time at Ground...
- Little Boy Tugs at Heartstrings of Entire Community: Be the Match!
Danny Feltwell, a young six-year-old boy, was diagnosed with T-cell lymphoblastic lymphoma when he was just two years old. After undergoing countless procedures and just four months from being considered fully cured, Danny relapsed and had to be re-hospitalized. The doctors found that a large tumor...